auditory brainstem response (Audio Logic Inc)
86
Structured Review
Audio Logic Inc
auditory brainstem response
Auditory Brainstem Response, supplied by Audio Logic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auditory+brainstem+response/auditory+brainstem+response/pm42279211-3-13-0
Average 86 stars, based on 1 article reviews
Auditory Brainstem Response, supplied by Audio Logic Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/auditory+brainstem+response/auditory+brainstem+response/pm42279211-3-13-0
Average 86 stars, based on 1 article reviews
auditory brainstem response - by Bioz Stars,
2026-09
86/100 stars
Images
Related Articles
other:Article Title: Middle Ear Effusion in Children With Congenital Cytomegalovirus Infection Article Snippet: Article Title: Comparison of Hearing Phenotypes Among Children With Congenital Cytomegalovirus and Other Non‐Cytomegalovirus Conditions Article Snippet: Article Title: Early cochlear implantation for children with single sided deafness. Article Snippet: Objectives: Single-sided deafness (SSD) can have consequences for a child’s language, educational, and social development.. A cochlear implant (CI) is the only device which can restore true binaural hearing, yet they are only approved for children with (SSD) over the age of five in the United States.. Reports on speech perception outcomes for children implanted at a younger age are limited. Magnetic Resonance Imaging:Article Title: Anesthesia outcomes in lysosomal disorders: CLN3 and GM1 gangliosidosis. Article Snippet: Funding information Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: ZIA HD008989 Abstract Natural history studies of pediatric rare neurometabolic diseases are important to understand disease pathophysiology and to inform clinical trial outcome measures.. Some data collections require sedation given participants' age and neurocognitive impairment.. To evaluate the safety of sedation for research procedures, we reviewed medical records between April 2017 and October 2019 from a natural history study for CLN3 (NCT03307304) and one for GM1 gangliosidosis (NCT00029965). Spectroscopy:Article Title: Anesthesia outcomes in lysosomal disorders: CLN3 and GM1 gangliosidosis. Article Snippet: Funding information Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: ZIA HD008989 Abstract Natural history studies of pediatric rare neurometabolic diseases are important to understand disease pathophysiology and to inform clinical trial outcome measures.. Some data collections require sedation given participants' age and neurocognitive impairment.. To evaluate the safety of sedation for research procedures, we reviewed medical records between April 2017 and October 2019 from a natural history study for CLN3 (NCT03307304) and one for GM1 gangliosidosis (NCT00029965). Tomography:Article Title: Anesthesia outcomes in lysosomal disorders: CLN3 and GM1 gangliosidosis. Article Snippet: Funding information Eunice Kennedy Shriver National Institute of Child Health and Human Development, Grant/Award Number: ZIA HD008989 Abstract Natural history studies of pediatric rare neurometabolic diseases are important to understand disease pathophysiology and to inform clinical trial outcome measures.. Some data collections require sedation given participants' age and neurocognitive impairment.. To evaluate the safety of sedation for research procedures, we reviewed medical records between April 2017 and October 2019 from a natural history study for CLN3 (NCT03307304) and one for GM1 gangliosidosis (NCT00029965). |